Correction to: Mol Med (2020) 26:98 https://doi.org/10.1186/s10020-020-00224-9
Following publication of the original article (Sitapara et al. 2020), the author requested to change the title of their re-published paper as follows:
From: The α7 nicotinic acetylcholine receptor agonist GTS-21 improves bacterial clearance in mice by restoring hyperoxia-compromised macrophage function
To: GTS-21, an α7nAChR agonist, increases pulmonary bacterial clearance in mice by restoring hyperoxia-compromised macrophage function
The original article has been corrected.
Reference
Sitapara RA, Gauthier AG, Patel VS, Lin M, Zur M, Ashby CR Jr, Mantell LL. GTS-21, an α7nAChR agonist, increases pulmonary bacterial clearance in mice by restoring hyperoxia-compromised macrophage function. Mol Med. 2020;26(1):98. https://doi.org/10.1186/s10020-020-00224-9.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Sitapara, R.A., Gauthier, A.G., Patel, V.S. et al. Correction to: GTS-21, an α7nAChR agonist, increases pulmonary bacterial clearance in mice by restoring hyperoxia-compromised macrophage function. Mol Med 27, 93 (2021). https://doi.org/10.1186/s10020-021-00357-5
Published:
DOI: https://doi.org/10.1186/s10020-021-00357-5